Cell therapy appears safe and effective for l

<p>A study led by researchers at <a href="https://umiamihealth.org/en/sylvester-comprehensive-cancer-center"><strong>Sylvester Comprehensive Cancer Center</strong></a>&nbsp;suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. Video available.</p>

Related Keywords

Miami ,Florida ,United States ,San Diego ,California ,American ,Mazyar Shadman ,Antoniom Jimenez ,Mehdi Hamadani ,Alexf Herrera ,Kwang Wooahn ,Manmeet Kaur ,Craigs Sauter ,Trent Wang ,University Of Miami Miller School Medicine ,A Center ,Sylvester Comprehensive Cancer Center ,Fred Hutchinson Cancer Center ,International Blood Marrow Transplant Research ,American Society Of Hematology ,Taussig Cancer Institute ,College Of Wisconsin ,Miami Miller School ,American Society ,International Blood ,Marrow Transplant Research ,Medical College ,Antigen Receptor ,Largeb Cell Lymphoma ,Complete Remission ,